SCHEMBL6643284

SCHEMBL6643284

COc1ccc(-c2cnc3c[c]ccc3n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.52
NPC1 O15118 9/20 0.48
MAPT P10636 5/20 0.48
KDM4E B2RXH2 3/20 0.48
RAB9A P51151 6/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
HPGD P15428 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PARP1 P09874 1/20 0.45
PDGFRB P09619 1/20 0.44
PDGFRA P16234 1/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL710433 0.80 NPC1 (0.71) MAPK1NPC1MAPTKDM4ERAB9A
SCHEMBL5885621 0.80 TLR9 (0.53) MAPK1NPC1MAPTKDM4ERAB9A
SCHEMBL5885440 0.78 ALDH1A1 (0.60) MAPTKDM4EALDH1A1HPGDL3MBTL1
SCHEMBL28617539 0.74 HTT (0.42) NPC1MAPTKDM4ERAB9AALDH1A1
SCHEMBL6639468 0.74 PDGFRB (0.51) NPC1KDM4ERAB9AALDH1A1HPGD
SCHEMBL8502224 0.74 ALDH1A1 (0.74) MAPK1NPC1MAPTKDM4ERAB9A
Hydrochloric Acid SCHEMBL8499941 0.73 ALDH1A1 (0.72) MAPK1NPC1MAPTKDM4ERAB9A
SCHEMBL17979213 0.72 FGFR3 (0.56) MAPK1KDR
SCHEMBL28860564 0.72 MAPK1 (0.54) MAPK1NPC1MAPTKDM4ERAB9A
SCHEMBL28165865 0.72 MAPT (0.61) MAPK1NPC1MAPTKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427421-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS Amgen Inc. (US) 2004-06-16 EP disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed